Evidence map›Paper›PMID 31309410›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Investigating the Proteomic Profile of HT-29 Colon Cancer Cells After Lactobacillus kefiri SGL 13 Exposure Using the SWATH Method.

Jessica Brandi, Claudia Di Carlo, Marcello Manfredi, Federica Federici, Alda Bazaj, Eleonora Rizzi, Giuseppe Cornaglia, Laura Manna, Emilio Marengo, Daniela Cecconi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Kefir revisited: Insights from the North Caucasus.World journal of experimental medicine · 2025
    Review
  2. Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Frontiers in nutrition · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jessica BrandiDepartment of Biotechnology, Proteomics and Mass Spectrometry Laboratory, University of Verona, Strada le Grazie 15, 37134, Verona, Italy.
Claudia Di CarloDepartment of Biotechnology, Proteomics and Mass Spectrometry Laboratory, University of Verona, Strada le Grazie 15, 37134, Verona, Italy.
Marcello ManfrediISALIT s.r.l., Novara, Italy.
Federica FedericiSintal Dietetics s.r.l., Castelnuovo Vomano, Teramo, Italy.
Alda BazajDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Eleonora RizziSintal Dietetics s.r.l., Castelnuovo Vomano, Teramo, Italy.
Giuseppe CornagliaDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Laura MannaSintal Dietetics s.r.l., Castelnuovo Vomano, Teramo, Italy.
Emilio MarengoCenter for Translational Research on Autoimmune & Allergic Diseases-CAAD, Novara, Italy.
Daniela CecconiDepartment of Biotechnology, Proteomics and Mass Spectrometry Laboratory, University of Verona, Strada le Grazie 15, 37134, Verona, Italy. daniela.cecconi@univr.it.ORCID http://orcid.org/0000-0002-7314-8941
University of Verona · ITUniversity of Teramo · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite some studies revealed that kefir acts on different cancers, such as colorectal cancer, the proteomic changes that occur in the colon cancer cells remain to be explored. In this study, the proteomic analysis was combined with determination of kefir characteristics (e.g., adhesion capacity, gastrointestinal and antibiotic resistances), in order to confirm its use as a probiotic. Therefore, a label-free strategy based on SWATH-MS was applied to investigate the proteomic profile of HT-29 cells after exposure for 24 h to a specific strain of Lactobacillus kefiri named SGL 13. We identified a total of 60 differentially expressed proteins in HT-29 cells, among which most are located into the extracellular exosome, playing important/crucial roles in translation and cell adhesion, as indicated by the enrichment analysis. The eIF2 and retinoid X receptor activation pathways appeared to be correlated with the anti-tumoral effect of SGL 13. Immunoblot analysis showed an increase in Bax and a decrease in caspase 3 and mutant p53, and ELISA assay revealed inhibition of IL-8 secretion from HT-29 cells stimulated with LPS upon SGL 13 treatment, suggesting pro-apoptotic and anti-inflammatory properties of kefir. In conclusion, the results of this study, the first of its kind using co-culture of kefir and colon cancer cells, demonstrate that L. kefiri SGL 13 possesses probiotic potency and contribute to elucidate the molecular mechanisms involved in the L. kefiri-colon cancer cell interactions.

Indexed as

HT29 CellsLactobacillusProbioticsBacterial AdhesionCell SurvivalDrug Resistance, BacterialHumansKefirMass SpectrometryMicrobial Sensitivity TestsProteomeProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationWorkflowProteomeColon cancerLabel-free proteomicsLactobacillus kefiriSWATH-MS

Identifiers

PMID31309410
OpenAlexW2959888314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.